Sign In
Buy RYTM
$84.71
+0.360 (+0.427%)
At Close: Jun 03, 2026
Rhythm Pharmaceuticals to Report Second Quarter 2023 Financial Results on Tuesday, August 1, 2023
02:12am, Saturday, 15'th Jul 2023
BOSTON, July 18, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families li
Rhythm Pharmaceuticals: Putting It On The Scale Again
07:08pm, Wednesday, 07'th Jun 2023
Today, we check back in on Rhythm Pharmaceuticals, Inc., an entrant into the fast-growing weight management medicine space. The company is simultaneously trying ramp up sales from its franchise drug w
Rhythm Pharmaceuticals to Present at Goldman Sachs 44th Annual Global Healthcare Conference
08:00am, Wednesday, 07'th Jun 2023
BOSTON, June 07, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families liv
Rhythm Pharmaceuticals, Inc. (RYTM) Q1 2023 Earnings Call Transcript
02:18am, Wednesday, 03'rd May 2023
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM ) Q1 2023 Earnings Conference Call May 2, 2023 8:00 AM ET Company Participants David Connolly - Executive Director of Investor Relations and Corporate Communi
Rhythm Pharmaceuticals to Present at 22nd Annual Needham Virtual Healthcare Conference
08:00am, Monday, 10'th Apr 2023
BOSTON, April 10, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families li
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
09:01pm, Monday, 06'th Mar 2023 GlobeNewswire Inc.
BOSTON, March 06, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families
Expert Ratings for Rhythm Pharmaceuticals
03:01pm, Thursday, 02'nd Mar 2023 Benzinga
Over the past 3 months, 4 analysts have published their opinion on Rhythm Pharmaceuticals (NASDAQ:RYTM) stock. These analysts are typically employed by large Wall Street banks and tasked with understa
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Tops Revenue Estimates
01:25pm, Wednesday, 01'st Mar 2023 Zacks Investment Research
Rhythm Pharmaceuticals, Inc. (RYTM) delivered earnings and revenue surprises of 8.54% and 24.56%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for th
Rhythm Pharmaceuticals, Inc. (RYTM) Reports Q4 Loss, Tops Revenue Estimates
09:47am, Wednesday, 01'st Mar 2023
Rhythm Pharmaceuticals, Inc. (RYTM) delivered earnings and revenue surprises of 8.54% and 24.56%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for th
Rhythm Pharmaceuticals Announces Acquisition of Xinvento B.V. and Portfolio of Investigational Therapeutics
01:45pm, Monday, 27'th Feb 2023 GlobeNewswire Inc.
- Rare disease company in preclinical development for congenital hyperinsulinism -
Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 1, 2023
01:00pm, Tuesday, 21'st Feb 2023 GlobeNewswire Inc.
BOSTON, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families l
Rhythm Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results on Wednesday, March 1, 2023
08:00am, Tuesday, 21'st Feb 2023
BOSTON, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families liv
3 Breakout Growth Stocks to Buy for the Long Haul
01:45pm, Monday, 09'th Jan 2023 The Motley Fool
These three have had big-time share gains backed up by breakthrough science.
3 Breakout Growth Stocks to Buy for the Long Haul
08:45am, Monday, 09'th Jan 2023
These three have had big-time share gains backed up by breakthrough science.
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
09:01pm, Thursday, 05'th Jan 2023 GlobeNewswire Inc.
BOSTON, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families l
